- A Pill for Sleep Apnea Could Be on the Horizon The New York Times
- Apnimed announces positive results from second clinical trial of sleep apnea medication American Academy of Sleep Medicine | AASM
- Apnimed firms up filing plans for oral sleep apnoea drug after second pivotal study win FirstWord Pharma
- Apnimed’s sleep apnea asset goes 2 for 2 in phase 3, solidifying star potential Fierce Biotech
- Positive Topline Results From Phase 3 Trial of AD109, First Oral Pill for Obstructive Sleep Apnea Psychiatric Times
Source link